SD Executive Committee Meeting as Conference Call - December 2020
From left to right - top to bottom:
Konstantinos Makris - Member; Paola Bramati - IFCC Office; Christa Cobbaert - Vice Chair; Joseph Passarelli - Secretary; Philippe Gillery - Chair; Michael Rottmann - Corporate Members Representative; Karen Phinney - NIST Consultant; Greg Miller - ICHCLR Observer; Barnali Das - Member; Ian Young - JCTLM Consultant; Mario Plebani - Member
A Committee on Standards was established in 1966 "to instigate and promote theoretical and practical developments in the field of standards and standardisation in clinical chemistry - in its broadest sense." During its first decade, the main efforts of the Committee were directed toward (1) analytical nomenclature, (2) reference materials and methods, and (3) quality control. Its achievements during this period are illustrated by the list of publications on these topics. Following a Council decision in 1978, efforts have been made to extend its work to include more subjects of interest both to clinicians and clinical chemists and laboratorians. Accordingly, the name of the Committee was changed to the Scientific Committee and later to the Scientific Division.
The Division and its activities are managed by an Executive Committee. This Committee is responsible for (1) developing a mission statement, (2) developing strategy and tactics, (3) initiating and managing projects, and (4) generating and adhering to its Terms of Reference.
The mission of the SD is to advance the science of Clinical Chemistry and Laboratory Medicine and to apply it to the practice of Clinical Laboratory Science.
According to the Statutes of IFCC, the Federation exists to advance the science and practice of Clinical Chemistry and to further its application in the provision of health services and the practice of medicine. The goals to which the Scientific Division is committed are to:
The SD initiates and manages projects with its own resources or through its Committees and Working Groups. Work is conducted in cooperation with other IFCC units and with relevant National and International Organisations. The SD ensures that each of its Committees and Working Groups are functioning under clear terms of reference together with an agreed schedule of activity. The SD will assist in the development of the project proposals, and will undertake an annual review of progress and review and approve any documents that result from the work.
Name | Position | Country | Term | Time in Office |
P. Gillery | Chair | FR | 2nd | 2020 01 - 2022 12 |
C.M. Cobbaert | Vice-Chair | NL | 2nd | 2020 01 - 2022 12 |
To be nominated | Secretary | |||
B. Das | Member | IN | 2nd | 2021 01 - 2023 12 |
K. Makris | Member | GR | 2nd | 2020 01 - 2022 12 |
M. Plebani | Member | IT | 2nd | 2020 01 - 2022 12 |
M. Rottmann | Corporate Member | DE | 1st | 2020 03 - 2022 12 |
G. Miller | ICHCLR Observer | US | ||
I. Young | JCTLM Chair / SD Consultant | UK | ||
H. Schimmel | JRC Observer | BE | ||
Y. Zhen | NIFDC Observer | CN | ||
C. Burns | NISBC Consultant | UK | ||
K. Phinney | NIST Consultant | US |
8.2.06 | Nomenclature, Properties and Units (C-NPU) in collaboration with International Union of Pure and Applied Chemistry (IUPAC) | Y.B.L. Hansen (DK) |
8.2.11 | Molecular Diagnostics (C-MD) | P. Ahmad-Nejad (DE) |
8.2.23 | Traceability in Laboratory Medicine (C-TLM) | A. Kessler (DE) |
8.2.24 | Reference Intervals and Decision Limits (C-RIDL) | Y. Ozarda (TR) |
8.2.25 | Standardization of Thyroid Function Tests (C-STFT) | H. Vesper (US) |
8.2.26 | Harmonization of Autoimmune Tests (C-HAT) | J. Sheldon (UK) |
8.2.26 | Bone Metabolism (C-BM) | E. Cavalier (BE) |
CHAIR Prof. Philippe GILLERY | VICE-CHAIR Prof. Christa M. COBBAERT |
SECRETARY To be nominated | MEMBER Dr. Barnali DAS |
MEMBER Dr. Konstantinos MAKRIS | MEMBER Prof. Mario PLEBANI |
CORPORATE REPRESENTATIVE Dr Michael ROTTMANN | EUROPEAN COMMISSION - JRC OBSERVER Dr. Heinz SCHIMMEL |
ICHCLR OBSERVER Dr. Greg MILLER | JCTLM CONSULTANT Prof. Ian S. YOUNG |
NIBSC CONSULTANT Dr. Chris BURNS | NIFDC Observer Dr. Yang ZHEN |
NIST CONSULTANT Dr. Karen W. PHINNEY |